Alois B. Lang
Corporate Officer/Principal presso University of Bern
Posizioni attive di Alois B. Lang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Bern | Corporate Officer/Principal | - | - |
Storia della carriera di Alois B. Lang
Precedenti posizioni note di Alois B. Lang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GENEURO SA | Corporate Officer/Principal | - | 31/12/2018 |
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Direttore Tecnico/Scientifico/R&S | 02/09/2006 | - |
| Fondatore | 02/09/2006 | - |
Formazione di Alois B. Lang
| Swiss Federal Institute of Technology | Doctorate Degree |
Statistiche
Distribuzione geografica
| Svizzera | 4 |
| Germania | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENEURO SA | Health Technology |
| Aziende private | 1 |
|---|---|
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Alois B. Lang
- Esperienza
